Detection of Immunotoxic Gluten Peptides in Feces

NCT01478867 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2011-11-24

No results posted yet for this study

Summary

The purpose of this study is to monitor of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces.

Conditions

Interventions

OTHER

Detection of gluten in feces

Detection of Gluten in Feces

Sponsors & Collaborators

  • Instituto Hispalense de Pediatría, Seville, Spain

    collaborator UNKNOWN
  • University of Seville

    lead OTHER

Principal Investigators

  • Carolina Sousa, Professor · University of Seville, Spain

Eligibility

Min Age
1 Year
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Completion
2011-07-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01478867 on ClinicalTrials.gov